Concepedia

Charles Gill

CG

30

Publications

3K

Citations

22

H-Index

1989

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

MSD (Spain)

Universidade Nova de Lisboa

University of Bonn

Charles Gill is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1989–2020

30

Publications

30

Platensimycin is a selective FabF inhibitor with potent antibiotic properties

Jun Wang, S.M. Soisson, Katherine Young et al. · Nature · 2006 · 809 citations

, , +11

Selective small-molecule inhibition of an RNA structural element

John A. Howe, Hao Wang, Thierry Fischmann et al. · Nature · 2015 · 411 citations

, , +3

Restoring Methicillin-Resistant <i>Staphylococcus aureus</i> Susceptibility to β-Lactam Antibiotics

Christopher M. Tan, Alex G. Therien, Jun Lü et al. · Science Translational Medicine · 2012 · 244 citations

Efficacy of the Echinocandin Caspofungin against Disseminated Aspergillosis and Candidiasis in Cyclophosphamide-Induced Immunosuppressed Mice

George K. Abruzzo, Charles Gill, Amy Flattery et al. · Antimicrobial Agents and Chemotherapy · 2000 · 170 citations · Full text

Discovery of Wall Teichoic Acid Inhibitors as Potential Anti-MRSA β-Lactam Combination Agents

Hao Wang, Charles Gill, Sang Hyub Lee et al. · Chemistry & Biology · 2013 · 134 citations · Full text

, , +8

Rows per page

1–5 of 30